Effects of GW274150, a novel and selective inhibitor of iNOS activity, in acute lung inflammation

Br J Pharmacol. 2004 Mar;141(6):979-87. doi: 10.1038/sj.bjp.0705683. Epub 2004 Feb 9.

Abstract

1. The aim of this study was to investigate the effect of GW274150, a novel, potent and selective inhibitor of inducible nitric oxide synthase (iNOS) activity in a model of lung injury induced by carrageenan administration in the rats. 2. Injection of carrageenan into the pleural cavity of rats elicited an acute inflammatory response characterized by: fluid accumulation in the pleural cavity which contained a large number of polymorphonuclear cells (PMNs) as well as an infiltration of PMNs in lung tissues and subsequent lipid peroxidation, and increased production of nitrite/nitrate (NO(x)), tumour necrosis factor alpha (TNF-alpha) and interleukin-1beta (IL-1beta). 3. All parameters of inflammation were attenuated in a dose-dependent manner by GW274150 (2.5, 5 and 10 mg x kg(-1) injected i.p. 5 min before carrageenan). 4. Carrageenan induced an upregulation of the intracellular adhesion molecules-1 (ICAM-1), as well as nitrotyrosine and poly (ADP-ribose) (PAR) as determined by immunohistochemical analysis of lung tissues. 5. The degree of staining for the ICAM-1, nitrotyrosine and PAR was reduced by GW274150. These results clearly confirm that NO from iNOS plays a role in the development of the inflammatory response by altering key components of the inflammatory cascade. 6. GW274150 may offer a novel therapeutic approach for the management of various inflammatory diseases where NO and related radicals have been postulated to play a role.

MeSH terms

  • Animals
  • Carrageenan
  • Disease Models, Animal
  • Enzyme Inhibitors / therapeutic use
  • Intercellular Adhesion Molecule-1 / biosynthesis
  • Interleukin-1 / biosynthesis
  • Interleukin-1beta
  • Lung / chemistry
  • Lung / drug effects
  • Lung / pathology
  • Male
  • Malondialdehyde / metabolism
  • Nitrates / metabolism
  • Nitric Oxide Synthase / antagonists & inhibitors
  • Nitric Oxide Synthase / metabolism*
  • Nitric Oxide Synthase Type II
  • Nitrites / metabolism
  • Peptide Fragments / biosynthesis
  • Peroxidase / metabolism
  • Pleuropneumonia / chemically induced
  • Pleuropneumonia / drug therapy
  • Pneumonia / chemically induced
  • Pneumonia / drug therapy*
  • Poly(ADP-ribose) Polymerases / biosynthesis
  • Rats
  • Rats, Sprague-Dawley
  • Sulfides / therapeutic use*
  • Tumor Necrosis Factor-alpha / biosynthesis
  • Tyrosine / analogs & derivatives*
  • Tyrosine / biosynthesis

Substances

  • Enzyme Inhibitors
  • Interleukin-1
  • Interleukin-1beta
  • Nitrates
  • Nitrites
  • Peptide Fragments
  • Sulfides
  • Tumor Necrosis Factor-alpha
  • GW 274150
  • interleukin-1beta (163-171)
  • Intercellular Adhesion Molecule-1
  • 3-nitrotyrosine
  • Tyrosine
  • Malondialdehyde
  • Carrageenan
  • Peroxidase
  • Nitric Oxide Synthase
  • Nitric Oxide Synthase Type II
  • Nos2 protein, rat
  • Poly(ADP-ribose) Polymerases